Immunochemical characterization of the "native" type III polysaccharide of group B Streptococcus by unknown
IMMUNOCHEMICAL  CHARACTERIZATION  OF  THE  "NATIVE" 
TYPE  III  POLYSACCHARIDE  OF  GROUP  B 
STREPTOCOCCUS* 
BY CAROL J.  BAKER,$  DENNIS L.  KASPER,  AND CHARLES  E.  DAVIS 
(From the Channing Laboratory, Harvard Medical School, and Boston City Hospital, Boston, 
Massachusetts 02115,  and the Department of Pathology, University of California at San Diego 
School of Medicine, La Jolla, California 92037) 
Since  Lancefield's classification of beta-hemolytic Streptococcus  in  1933  (1), 
organisms designated Group B have been reported as a cause of human disease. 
Their emergence as frequent neonatal  pathogens, however, is an event of this 
decade.  Two distinct  types of illness  that  are related to age at onset  (2,3)  are 
described for neonates with infections due to Group B Streptococcus.  The "early 
onset type" of infection occurs in neonates 5 days of age or less (2), results from 
intrapartum  transmission  of organisms from the  maternal  genital  tract,  and 
causes  a  mortality  rate  in  excess  of  50%.  "Late  onset  type"  infections,  in 
contrast,  are characterized by onset beyond the 10th day of life and are associ- 
ated  with  purulent  leptomeningitis,  significantly  lower  mortality  rates,  and 
modes of transmission in addition to the mother-to-infant route (4). 
These two clinical  syndromes have been related to certain serotypes. The serologic 
classification of Group B streptococci is based upon capillary precipitin tests with hyper- 
immune  rabbit  antisera  and  acid-extracted  antigens  (5). By  this  method,  Group  B 
streptococci can be divided into serotypes Ia, Ib, Ic, II, and III (5-7). Serotyping of strains 
has allowed the epidemiologic characterization of neonatal infection. Organisms isolated 
from  asymptomatic mothers  and  neonates  with  Group  B  streptococci  have virtually 
identical distributions of serotypes; 26% of strains are type Ia, Ib, or Ic; 38% are type II, 
and 36% are type III (8). This distribution of serotypes is similar among isolates from 
neonates who have early onset type septicemia without meningitis. However, neonates 
who have early onset type infection with meningitis and infants with  late onset type 
infection have a striking predominance of type III isolates (:>80%) (8-10). These epidemio- 
logic observations suggested that  strains  of Group B  streptococci of serotype HI may 
possess  invasive  properties  that  allow  meningeal  penetration  and  the  production  of 
disease beyond the first few days of life. 
Lancefield has immunochemically characterized two polysaccharides from Group B 
Streptococcus: the group-specific B polysaccharide antigen common to all strains and the 
type-specific polysaccharide antigen which  allows classification into four distinct sero- 
types:  Ia,  Ib,  II, and  III (5,6).  These  type-specific petysaccharides are believed to be 
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capsular antigens which are chemically and serologically distinct from each other and 
from the group-specific substance. An additional serotype, type Ic, has been defined by 
Wilkinson  and  Eagon  (7). Type Ic strains possess a  polysaccharide  antigen  which  is 
immunochemically identical to the type Ia antigen (11); in addition, type Ic strains have a 
protein  antigen,  the  Ibc protein,  which  is  found  in  all  type  Ib  and  Ic  strains  and 
infrequently in strains of type II and HI. 
Classical methods of extracting polysaccharide antigens from Group B Streptococcus 
for serogrouping and serotyping have utilized hot HC1 treatment of whole organisms. 
Additional purification methods are necessary, however, for separation of group- from 
type-specific substances. Recent investigations of the type I polysaccharides by Wilkinson 
(11),  the  type II polysaccharide  by Lancefield  and  Freimer (12, 13), and the type III 
polysaccharide  by  Russell  and  Norcross  (14) have  used  alcohol  fractionation  or  ion 
exchange chromatography for the separation of type-specific polysaccharides from the 
group-specific substance.  However,  these  HCl-treated  antigens  are  incomplete,  low- 
molecular weight substances which have previously been reported to contain varying 
quantities of glucose, galactose, and glucosamine. For the isolation of the type-specific 
antigens from serotypes Ia, Ib, Ic, and II, extraction with cold trichloracetic acid (TCA) 
results in more "complete" polysaccharides with a labile component identifiable as sialic 
acid (11, 12,  15). This sialic acid component accounted for approximately 12% of the dry 
weight  of the  type  II-TCA antigen  (12). More  gentle  methods  for  the  isolation  and 
immunochemical  definition  of the  type  III polysaccharide  have  not  been  previously 
reported. 
We have isolated and purified the type III polysaccharide in ~'native" form by 
means of an extraction procedure in which  whole bacteria are washed with  a 
neutral buffer solution. This polysaccharide has a  mol wt >5  ×  l0  s daltons. Its 
main chemical constituents are sialic acid (24%), galactose (25%), heptose (21%), 
glucose  (13%),  glucosamine  (10%).,  and  mannose  (7%).  The  antigen  has  type- 
specificity with  homologous  and  heterologous  antisera  prepared  to  formalin- 
treated  and  live  organisms.  Preparation  of  type-specific  antisera  with  live 
organisms was believed to be  a  potentially  more  accurate  means  of studying 
antibodies that form in response to naturally occurring antigens.  By the use of 
antiserum prepared to a  live homologous type III strain, a  previously unknown 
cross-reactive II-III  antigen has been demonstrated. The goal attempted through 
immunochemical  study  of purified  antigens  of the  bacterial  cell  surface  is 
isolation of antigens in native form. Native antigens are desirable for investiga- 
tive  purposes  because  they  most  closely  resemble  that  which  the  naturally 
infected host recognized immunologically. 
Materials  and  Methods 
Bacterial  Strains.  Prototype strains of Group B Streptococcus  representing each of the five 
serotypes and the Group B variant strain (devoid of type-specific antigen) were kindly supplied by 
Dr. Rebecca Lancefield. These strains are designated 090 (Ia), H36B (Ib), A909 (Ic), I8RS21 (II), 
D136C (III), and 090R (group  B).  Lyophilized strains were rehydrated with Todd-Hewitt  broth 
(Difco Laboratories, Detroit, Mich.) and incubated overnight at 37°C before use. In addition,  type 
HI strains M731, M732, and M735 isolated (in Houston) from three infants with meningitis were 
stored at -70°C in 1-ml aliquots of Todd-Hewitt broth. 
Media and Growth  Conditions.  Strains M731 or M732 were inoculated  into an Erlenmeyer 
flask containing 200 ml of Todd-Hewitt  broth and were incubated  for 12 h  at 37°C. From this 
culture, 60--70-liter lots were inoculated  and grown for 12 h at 37°C in a modified Tedd-Hewitt 
broth. This modified medium was prepared by increasing eightfold the concentration of Na~I-IPO4. 
Standard Todd-Hewitt broth has an initial pH of 7.4, but this medium is acidified to pH 5.9 after 12 260  NATIVE  TYPE  III  POLYSACCHARIDE  OF  GROUP  B  STREPTOCOCCUS 
h  of growth of Group B  streptococci  (16). Because of the degradation  of certain polysaccharide 
antigens during accumulation of acid in a  culture medium (17), the buffering capacity of Todd- 
Hewitt was increased to maintain a more neutral pH during exponential growth. With use of the 
eightfold increase of Na2HPO4,  the pH of Todd-Hewitt broth was always >6.5 after 12 h of growth 
(16). All lots of the type III organisms were harvested at 4°C by continuous flow centrifugation by 
means of a model RC5 centrifuge with a SZ-14 rotor (Ivan Sorvall, Norwalk, Conn.). All cultures 
were checked to document purity at the end of the growth cycle. 
Electron Microscopy.  Strain M731 was prepared for electron microscopy by means of a modifi- 
cation of the method of Devoe and Gilchrist (18). Suspensions of whole organisms grown for 12 h in 
modified Todd-Hewitt broth were prefixed to adjust the final concentration of fixative to 0.5% by 
the addition of 2.5% glutaraldehyde in 0.1 M Na cacedylate buffer to the broth.  CaCI  2 (concentra- 
tion, 0.05%)  was added to this suspension.  After prefixation for 2 h  at 4°C, the suspension was 
centrifuged at 12,000 g. The pellet obtained was fixed in 2.5% buffered glutaraldehyde for 2 h  at 
4°C, washed with buffer, and postfixed for 1 h  in aqueous 1% OsO4. 
The pellet was then treated with 0.5% uranyl acetate in Michaelis buffer (pH 5) for 2 h at 4°C. 1- 
ram blocks were dehydrated in graded alcohols and embedded in Epon 812 according to the method 
of Luft (19). Thin sections were stained with lead citrate and examined in a Jem 100B electron 
microscopy (Japan Electron Optics Laboratory, Tokyo, Japan). 
Extraction  of HCl Antigens.  Prototype strain D136C and serotype III strains M731 and M732 
were exposed to 0.2 N HCI for 10 rain at 100°C, as described by Lancefield (6). After neutralization 
of acid-treated  suspensions,  organisms  were  removed  by  centrifugation  at  2,000  g,  and  the 
supernatant  solution containing both group- and type-specific antigens were precipitated with 4 
vol of absolute  ethanol  at  4°C  for  4  h.  After centrifugation  and  drying,  antigens  were  then 
suspended in water and lyophilized. No further purification of these HC1 antigens was attempted. 
Preparation  of'Native  '' Type III Antigens.  Pelleted organisms from 60-70- liter lots (110-140 
g, wet weight) were suspended in a buffer containing 0.05 M sodium phosphate, 0.15 M NaC1, and 
0.01  M ethylenediaminetetraacetate  disedium (EDTA) adjusted to pH 7.4.  The final volume was 
approximately one-fiftieth that of the original culture. This suspension of organisms was stirred 
with glass beads at 24°C for 15 h. Washed cells were then removed by centrifugation at 12,000 g, 
and the supernatant  solution was filtered to remove residual bacteria by means of a  Millipore 
membrane (diameter, 0.45 pm; Millipore Corp., Bedford, Mass.). This preparation had both Group 
B and type III serologic activity. 
Removal of Nucleic  Acids  and Proteins.  Absolute  ethanol  was  added  to  the  concentrated 
preparation to make a final concentration of 25% vol/vol. This suspension was placed at 4  ° C for 4 
h, and nucleic acid precipitates were removed by centrifugation at 12,000g for 10 min. By means of 
fractionation with absolute ethanol at a concentration of 80% vol/vol, a white flocculent material 
was obtained. After centrifugation at 8,000g for 10 min, this material was resuspended in 20-30 
ml of phosphate-buffered saline (pH 7.4). The suspension was centrifuged at 80,000g at 4°C for 1 h. 
A  small precipitate was discarded.  The solution was double digested at 37°C with bovine pan- 
creatic deoxyribonuclease and ribonuclease (Worthington Biochemical Corp., Freehold, N. J.) at 
final concentrations of 0.1 mg/ml and 0.5 mg/ml, respectively. Pronase B (Calbiochem, San Diego, 
Calif.) at a  concentration of 0.5  mg/ml was then added at 37°C.  Both enzyme treatments were 
performed for 3 h. 
Final Purification.  The enzyme-treated supernate  was chromatographed  on a  2.6  x  100-cm 
column containing Sepharose  4B  (Pharmacia,  Uppsala,  Sweden)  equilibrated  in  0.01  M  Tris- 
(hydroxymethyl)  aminomethane-HC1  buffer,  pH  7.3.  The column was calibrated  with  dextran 
standards  (blue dextran,  T150 and T500).  4-ml fractions were collected. Separation of group B- 
from type III-specific antigens was achieved. The type III antigen eluted in the void volume of the 
column. 
The void volume fractions  (peak 1)  were pooled,  concentrated in an ultrafiltration  cell  with a 
PM-30 membrane (Amicon Corp., Lexington, Mass.)  to  5 ml. After addition  of  0.5  ml of  2 M  NaCI, 
the type Ill antigen was recovered by precipitation  for 4 h with absolute ethanol to make a 
concentration of  80% vol/vol.  After  centrifugation  (6,000  g)  and  reeusponsion in  distilled  water, the 
peak i material was lyophilized.  In general, 60- to 70-1iter  lots  of  type Ill organisms yielded 
approximately 3 mg of purified type III polysaccharide. 
Radiolabeling of Polysaccharides.  The  polysaccharide  antigens  were  intrinsically  labeled 
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10 mCi [~H]glucose per 10 liters of broth culture; purification of 3H type III polysaccharide was 
achieved by methods identical to those described above. 
Analytical  Methods.  The protein content of each lot of type III polysaccharide was determined 
with the method of Lowry et al. (20) by comparison to a bovine serum albumin standard. Nucleic 
acid content was estimated by the ratio of ultraviolet light absorbed at 280 pm and 260 ~xn (21). 
The method of Chen et al. (22) was used for the microdetermination of phosphorus with the group 
A polysaccharide ofNeisseria meningitidis  (mannosamine phosphate) as a standard. The method 
of Alcino (23) was used to detect the presence of 0-acetyl groups with the group C polysaccharide of 
N. rneningitidis  as a control. The susceptibility to enzymatic cleavage by the neuraminidase from 
Clostridium  perfringens  was determined by the method of Cassidy et al.  (24) with the Group B 
polysaccharide ofN. meningitidis as a  standard. 
Chromatographic  Techniques.  Gas-liquid chromatographic analysis of the purified type III 
polysaccharide was performed after trimethylsilyl derivatives of standard sugars were prepared in 
a  manner similar to that described by Davis and Arnold (25).  Briefly, gas chromatography was 
performed after  methanolysis of  the  type  III  substance  in  0.i  N methanolic-HCl at  80°C overnight. 
The methanol phase was extracted three times  with 2  vol  of  hexanes, and the  hexane phases were 
removed and discarded.  The acid in the methanol phase was neutralized with NH4OH  to  pH 7.0. 
The sample was then dried in a Buchler flask  evaporator  (Buchler Instruments Div., Searle 
Analytic  Inc.,  Fort  Lee, N.  J.),  and the  dried  sample was washed from  the  evaporation flask  with  2 
ml of methanol. The methanol was removed from the sample by flowing under a stream of 
nitrogen. Trimethylsilyl derivatives were then prepared by adding 0.2 ml of  a freshly  prepared 
solution  of  pyridine:hexamethyldisilazane:trimethylchlorosilane (2:0.8:0.2)  (Applied Science,  Inc., 
State College,  Pa.).  The positive  identification  of  all  sugars  was proved  by  cochromatography with 
similarly  prepared standard sugars  or  endotoxin  from  Escherichia  coli  0:111.  The 0:111  endotoxin, 
however, was hydrolyzed with 0.5 HCI. The identification  of  all sugars in the 0:111,  including 
heptose, has previously been proved by mass spoctrophotometry  (26). 
Samples were studied on a Hewlett-Packard 402 gas chromatograph fitted  with a 6 foot,  U- 
shaped, 3% SE-30  column (Hewlett-Packard Corp.,  Avondale, Pa.).  Samples were applied with an 
oven temperature  of  160°C until  identification  of  neutral and  amino sugars  was complete; the  oven 
temperature was then increased to 200°C for  the identification  of  sialic  acid. 
Serological  Methods.  Capillary precipitin  tests  were performed by the method of  Lancefield 
(27), and immunodiffusion tests  were done with the agar-gel method of Ouchterlony (28).  All 
antigen preparations were adjusted to  make equivalent concentrations.  Slides  for  immunoolectro- 
phoresis were prepared by the method of  Scheidegger (29).  Electrophoretic  migration of  antigens 
was achieved  by  the  use  of  a field  strength of  40  A per  slide  in  a sodium  barbitol  buffer  (pH  8.6)  for  4 
h at 24°C. 
Preparation ofAntisera. New Zealand  white rabbits  were immunized with formalinized whole 
cell vaccines of prototype, M731 and M732 strains of Group B Streptococcus according to the 
methods described by McCarty and Lancefield (30).  For type Ic antiserum of strain A909, the 
method of  Wilkinson was used (7).  Types Ia,  Ib, and Ic  antisera  were made specific  by absorption 
methods previously  described (11).  Antisera to  live  prototype,  M731, M732, and M735 strains  were 
prepared by intravenous  injections  of bacteria into  rabbits three times weekly. A  schedule of 
weekly logarithmic dose increases from 101 to 109 colony-forming units was completed. If  large 
inocula of organisms were administered initially,  a 100% mortality rate was observed among 
rabbits. With use of this  dose schedule, approximately 30% of the animals developed chronic 
infection  usually manifested as septic  arthritis  and osteomyelitis,  and 20% of  the animals died. 1 
wk after  completion  of  immunization, healthy  rabbits  were exsanguinated. All  sera  were stored  at 
-70°C in 1-2-mi aliquots  without preservatives. 
Results 
Electron Microscopy.  The cell  morphology of Group B Streptococcus,  type 
HI, was investigated  by electron  microscopy (Fig.  1). This organism demon- 
strated  bilaminar morphology typical  of  other gram-positive aerobic  cocci.  The 
outer moderately electron-opaque layer  observed is  probably analogous to  that 
of Group A  Streptococcus devoid of protein antigens (31).  This outer layer 
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Fro.  1.  Electron micrograph of thin sections of a  12-h culture of Group B Streptococcus 
(strain M731); OL, outer lamina; IL, inner layer of the cell wall. Magnification ×  72,000. 
electron-dense, inner layer was exterior to the indistinct cytoplasmic mem- 
brane. 
Preparation of Native Type III Polysaccharides.  By washing of organisms 
with a  neutral buffer solution, native polysaccharide antigens were isolated. 
Separation  of the  type  HI  antigen  from  Group. B  antigen  in  this  purified 
preparation was achieved by gel chromatography as shown in Fig. 2. For this 
experiment, strain M731 was grown in the presence of [3H]glucose. The elution 
profile of this preparation demonstrated two peaks of radioactivity. The first, 
peak 1, was eluted at the void volume of the Sepharose 4B column; this finding 
indicates a  molecular size of >5  ×  10  s daitons.  The second,  peak  2,  had  a 
calculated molecular size of approximately 50,000 daltons.  After pooling and 
concentration of peak 1 and peak 2 fractions separately, serologic testing with 
standard antisera was performed. The large molecular weight pelysaccharide 
(peak  1)  contained only type III  serologic reactivity.  Peak  2  had  Group  B 
serologic activity and small amounts of type III activity. The molecular sizes of 
several lots of type III polysaccharides (peak 1), prepared from this and other 
type III strains, were virtually identical. Further characterization of the peak 2 
polysaccharide preparation will not be described in this report. 
In cultures of type III strains grown for 12 h in modified Todd-Hewitt broth, 
Group  B-  and  type  III-specific antigens  were  readily detected by  capillary 
precipitin tests of the culture supernate. However, purification of antigens from 
these supernates was impractical on a preparative scale. Therefore, extraction 
of polysaccharides from whole organisms was necessary. 
Immunological Properties of the Type III Polysaccharide Antigen.  The na- 
tive type III polysaccharide of Group B Streptococcus reacted readily with type 
III-specific antisera in capillary precipitin and agar-gel diffusion tests. In Fig. 3 
a  single immunoprecipitin was noted with  antiserum prepared to  formalin- CAROL  J.  BAKER,  DENNIS  L.  KASPER,  AND  CHARLES  E.  DAVIS  263 
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Fro.  2.  Chromatographic  separation  of the  type  III  and  Group  B  polysaccharides  on 
Sepharose 4B gel. The elution profile for the 3H-labeled antigens of strain M731 extracted in 
EDTA buffer is shown. Elution of molecular size markers are indicated: void, blue dextran 
(mol wt > 5 x  10% dextran T500 (mol wt: 509,000),  and dextran Tll0 (mol wt: 116,000).  Solid 
line, 3H cpm per 50-/~1 sample. 
FIG.  3.  Immunediffusion in agar of purified "native" type III antigen from strain  M732 
with formalin-prepared type- or group B-specific rabbit antisera against prototype strains. 
Center well (2), type III antigen; antisera used are shown clockwise: upper well, anti-M732 
(type III), anti-090 (type Ia), anti-H36B (type Ib), anti-Ag09 (type Ic), anti-18RS21 (type II), 
and anti-090R (Group B variant). 
treated  cells  of the  homologous  type  III  strain.  High  concentrations  of this 
antigen  did  not  react  with  Group  B-specific  (090R)  or  type-specific  antisera 
prepared to strains other than serotype III. The relationship between the crude 
HCl-extracted and the native type III antigens from strains M731 and M732 was 
demonstrated in agar-gel  diffusion (Fig.  4).  Each of these antigens  formed an 
immunoprecipitin  with type HI antiserum prepared to a  formalin-treated  vac- 264  NATIVE  TYPE  III  POLYSACCHARIDE  OF  GROUP  B  STREPTOCOCCUS 
FIG.  4.  Immunodiffusion in agar of native type III (P1)  and HC1 antigens from strains 
M731 and M732 against rabbit antiserum to strain M732 in center well (2). 
FIG.  5.  Immunoelectrophoretic comparison of native type III polysaccharide (P1-732)  and 
HC1 antigen  (HC1-732) from strain  M732.  Antisora prepared  with formalin-treated  orga- 
nisms (B-090R),  Group B-specific; F-732, type III specific; and antiserum prepared with live 
cells (L-732) are shown in troughs. 
cine of whole cells from strain M732. A line of identity was seen between the 
native type III antigens of strains M731 and M732; each of these immunoprecipi- 
tins formed partial identities with HCl-extracted antigens prepared from the 
same strains. The experiments of Lancefield and Freimer (12,13) (II-HC1 anti- 
gen) and Wilkinson (11) (Ia-HC1, Ib-HC1, and Ic-HC1 antigens) suggested that 
acid and heat extractions of Group B streptococcal organisms resulted in partial 
hydrolysis of the native type antigens. These observations were confirmed by 
treating the native type III antigen with HC1 at 100°C for 10 rain which resulted 
in an antigen identical in immunologic reactivity to the HCl-extracted antigen. 
Thus, the native type HI polysaccharide extracted in neutral buffer is degraded 
to a less complete form by acid hydrolysis. 
Immunoelectrophoresis  afforded another means of  examining the relationship 
between the HCl-extracted and the native type HI antigens. The difference in 
the net charge of these two antigens is shown in Fig. 5. The native preparation 
(peak 1) of  type III pelysaccharide  from strain M732 migrated towards the anode, 
whereas the homologous HCl-extracted antigen migrated in the opposite direc, 
tion. Thus, the native type III antigen had a net negative charge. No Group B- 
specific precipitins are identified with the native type HI substance, a finding 
that indicates its purity. Antisera prepared to both live and formalinized inocula 
reacted identically to the native type HI polysaccharide extracted from strai  n 
M732. 
The large molecular weight type III polysaccharide from strain M731 (Fig. 6, CAROL J.  BAKER,  DENNIS  L.  KASPER,  AND  CHARLES  E.  DAVIS  265 
FIG.  6.  Immunodiffusion in agar of native type III polysaccharide (center well, 1) from 
strain M731 with rabbit antisera prepared to homologous and heterologous live (L) and 
formalin-treated (F} type III strains. Strains used indicated by number adjacent to wells. 
FiG.  7.  Immunodiffusion in agar of native type III polysaccharide (center well, 2) from 
strain M732 with rabbit  antisera prepared  to homologous and heterologous live (L) and 
formalin-treated (F) type III strains. 
center well) and from strain M732 (Fig.  7, center well) were studied by double 
diffusion in agar. The outer wells, shown in figures, contained antisera prepared 
to formalin-treated and live cells of several type HI strains. Both native type III 
polysaccharides from M731 and M732 react with lines of identity against all of 
these type III-specific antisera, indicating that the peak 1 substance indeed con- 
tained the  type HI-specific  antigen.  However,  the peak  1 preparation from 
strain M731 (Fig. 6) formed a second immunoprecipitin with rabbit antiserum 
prepared to live cells of the homologous strain. This second line of identity was 
not seen with antisera prepared to formalinized or live cells of the heterologous 
type III strains. This second antigen detected only in strain M731 is believed to 
represent a minor antigen with shared strain specificity. This antigen was read- 
ily detected by immunoelectrophoretic  analysis and like the type III substance 
it migrated towards the anode (Fig. 8). This second antigenic substance from 
strain M731 was found to react with antiserum prepared to a single live type II 
organism (18R21). This  type II-III  minor cross-reaction has  not been noted 
previously and was not demonstrated with antiserum prepared to formalinized 
cells of the homologous type HI strain. 
Chemical Composition.  The chemical composition of the  native type HI 
polysaccharide is summarized in Table I. The constituents from several lyophi- 
lized lots of antigen are listed as percentages of dry weight. Negligible amounts 
of protein, nucleic acid, and phosphorus were noted, a finding that assured lack 
of contamination of the  type  HI  antigen  with  mucopeptide or  cytoplasmic 
membrane components of the cell wall.  The carbohydrate composition of the 
native type HI polysaccharide was studied by gas-liquid chromatography  (Fig. 9, 
Table I). Galactose accounted for 25% of the carbohydrate present; its anomers 266  NATIVE  TYPE  III  POLYSACCHARIDE  OF  GROUP  B  STREPTOCOCCUS 
Fro.  8.  Immunoelectrophoresis  of  native type III polysaccharide  (P1-731)  and HC1 antigen 
(HC1-731) from strain M731. In troughs are Group B-specific  (B-090R) and type III-specific 
rabbit antisera prepared against formalin-treated (F731) and live (L-731) cells. 
TABLE I 
Composition of Type III Native Polysaccharide 
Constituent  Assay method  Dry weight 
of total 
Sialic acid  GLC*  24 
Galactose  GLC  25 
Heptose  GLC  21 
Glucose  GLC  13 
Glucosamine  GLC  10 
Mannose  GLC  7 
Protein  Lowry (19)  2-7 
Nucleic acid  UV absorption (20)  ND$ 
Phosphorus  Chen (21)  ND 
* GLC, Gas-liquid chromatography. 
ND, Not detectable. 
are seen as the first three eluted peaks.  Mannose, however, cochromatographs 
with a-galactose. Previous studies have shown the a- and 13-anomers of galac- 
tose  are  present in  equal  quantities  (26).  The quantitative  determination of 
mannose (7%) was achieved by subtracting the area under the ~-galactose peak 
from the area under the a-galactose peak. In addition to galactose and mannose, 
the  chemical constituents of the  type III  polysaccharide were glucose (13%), 
glucosamine (10%),  a  sugar tentatively identified as heptose (21%),  and sialic 
acid (24%). 
Digestion  of the  native  type HI  polysaccharide with  neuraminidase  from 
Clostridium perfringens  failed to destroy the  immunologic reactivity of this 
antigen.  No  O-acetyl  groups  were  identified  in  several  lots  of the  purified 
preparation of antigen. 
Relationship  to  Other Sialic Acid Antigens.  In  addition  to  the  Group B 
Streptococcus, the other common pathogen associated with neonatal meningitis 
is Escherichia coll.  The significant prevalence of type III strains of Group B 
streptococci among isolates from neonates with meningeal invasion is analogous 
to the prevalence of capsular type K1 strains ofE. coli (32). The KI pelysaccha- 
ride is a  homopolymer of sialic acid and is immunochemically identical to the CAROL  J.  BAKER,  DENNIS  L.  KASPER,  AND  CHARLES  E.  DAVIS 
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FIG.  9.  Methyl ester trimethysilyl ether derivatives of sugar of native type III antigen 
chromatographed on 6-foot glass columns packed with 3% SE-30 on Chromosorb W. Carrier 
gas was nitrogen 40 ml/min. Initial oven temperature was 160°C with injector and detector 
temperatures of 210°C. ~ indicates oven temperature changed to 200°C; injector and detecter 
temperatures to 230°C.  (1) a-galactose plus mannose; (2) ~-galactose; (3) ~-galactose; (4) a- 
glucose; (5) B-glucose; (6) N-acetyl-glucosamine; (7) heptese; (8) N-acetyl sialic acid. 
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Group B pelysaccharide ofN. meningitidis  (33). Since a major chemical constitu- 
ent  of the  native  type  III  pelysaccharide was  sialic  acid,  immunodiffusion 
analysis of the type III  and  KI  antigens with  high-titered horse  antiserum 
prepared to Group B N.  meningitidis  (kindly supplied by Dr.  John Robbins, 
Bureau of Biologic,  Food,  and Drug Administration, Washington, D. C.) was 
performed. Although a line of identity was formed between the polysaccharides 
ofE. coli K, and Group B meningococcus, no immunoprecipitins were observed 
with the type HI polysaccharide. Therefore, the native type III polysaccharide 
did  not  appear  to  share  antigenic determinants with  these  two  sialic  acid 
antigens.  This finding was not surprising,  however, since many sialic acid- 
containing bacterial  antigens  occur in  nature  and  immunologic identity is 
uncommon. Furthermore, no data is available to suggest that the sialic acid 
constituent of the native type HI pelysaccharide is immunodominant. 
Discussion 
Isolation of a native polysaccharide with type III serological specificity was 
achieved by washing of intact type III cells of Group B Streptococcus at neutral 
pH. The more complete nature of this native type III antigen is suggested by its 
very large molecular size and its immunochemical relationship to the classical 
HCl-extracted type III  antigen.  A  partial  identity was formed between the 
native type HI and the classical HCl-extracted antigens in immunodiffusion 
with type III-specific antiserum. Treatment of the native III antigen with hot 
HC1 resulted in hydrolysis to a substance immunologically identical to the HC1 
antigen. Net charge differences between the native and the HC1 antigens were 
detected  by immunoelectrophoresis. The native type III polysaccharide migrated 
towards the anode, an observation that indicated its net negative charge and its 
acidic nature. These data indicate that type HI antigen prepared by means of 
classical HC1 methods is a fragment of the native type antigen. Therefore, the 
large molecular weight, native type HI polysaccharide contains an acid-labile 
determinant. 
Previous immunochemical analysis of a type III antigen (strain D136C) was 
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HCl-extraction method of Lancefield to isolate a type-specific substance with a 
molecular size of approximatley 15,000 daltons. The constituents of this sub- 
stance were galactose, 38.9%, glucosamine, 22.8%, and glucose, 17.8%. Although 
each of these three sugars were identified in the native type HI polysaccharide, 
they only accounted  for 48% of  the total carbohydrate  weight. The native type HI 
antigen contained three additional sugars: sialic acid, heptose, and mannose. 
Particularly interesting was the identification of sialic acid and a heptose which 
accounted for 45% of the carbohydrate constituents. The presence of a heptose in 
a  cell wall antigen from this gram-positive organism is an unusual finding. 
Heptose is usually a constituent of the inner core of bacterial endotoxins (34). 
The present study describes a method of preparing type-specific antisera for 
Group  B  Streptococcus  by  means of immunization with  live  bacteria.  This 
method was believed to most closely approximate antigenic challenge during 
natural infection. With use of antisera prepared by this method, a carbohydrate 
antigen was detected in a single type HI strain (M731) which was immunologi- 
cally distinct from the native type IH polysaccharide. Furthermore, antibody to 
this additional polysaccharide antigen was identified in antiserum prepared to a 
single live type II strain. With antisera prepared to formalinized type II or type 
HI organisms, however, this additional antigen could not be detected. The rarely 
observed phenomenon of cross-reaction between type II  and type HI  strains 
during serotyping may be  explained by the presence of this  additional sub- 
stance. 
Approximately 80% of the cases of neonatal meningitis are caused by type III 
strains of Group B Streptococcus  and strains of capsular type K1E. coli (9, 35). 
Robbins  et  al.  suggested that  the  KI  antigen  was  a  "virulence" factor for 
meningeal invasion in neonates, since 84% of isolates from cerebrospinal fluid 
and only 39% of isolates from blood contained K1 antigen (32). Their findings for 
neonatal meningitis due to E. coli are analogous to those observed for meningi- 
tis due to Group B Streptococcus,  in which 91% of isolates from cerebrospinal 
fluid and 38% of isolates from blood contain type HI polysaccharide (9). A major 
chemical constituent of these two polysaccharide antigens is sialic acid, but they 
do not share antigenic determinants when studied by the methods used in this 
investigation. Therefore, the presence of sialic acid in certain bacterial antigens 
may account for their ability to invade the meninges of neonates. However, a 
recent investigation has confirmed the presence of sialic acid constituents in all 
of the serotype antigens of Group B Streptococcus  (36), yet epidemiologic data 
indicate  that  only the  strains  containing  the  type III  polysaccharide have 
propensity for meningeal invasion. Furthermore, the overwhelming majority of 
infants asymptomatically  colonized with type III strains of Group B streptococci 
remain well (8), suggesting that factors other than the chemical constituents of 
the bacterial cell wall may be important in the pathogenesis of neonatal Group 
B streptococcal infections. 
Summary 
The type III polysaccharide of Group B Streptococcus  has been isolated and 
purified by a method that employs washing of intact cells at neutral pH. That 
the polysaccharide prepared by this procedure is the "native" type HI antigen is 
suggested by its molecular size in excess of l0  s daltons, its degradation by acid CAROL  J.  BAKER,  DENNIS  L.  KASPER,  AND  CHARLES  E.  DAVIS  269 
and  heat  treatment  to  a  fragment  with  immunologic  characteristics  of the 
classical  HC1  antigen,  and  its  type-specific  serologic  activity.  The  type  HI 
polysaccharide in native form contains  sialic acid, galactose,  glucose,  glucosa- 
mine, heptose, and mannose. It is acidic in nature, is resistant to neuramindiase 
degradation, contains no O-acetyl groups, and does not share antigenic determi- 
nants with capsular type K~ antigen ofEscherichia coli or Group B  polysaccha- 
ride antigen of Neiserria meningitidis. 
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